Literature DB >> 11720151

The failed probing.

B A O'Donnell1, J P Adenis, J V Linberg, G E Rose, T J Sullivan, J L Wobig.   

Abstract

The management of failed probing for congenital nasolacrimal duct obstruction is given by a panel of authors. Treatment options examined are repeat probing, inferiorturbinate infracture, closed lacrimal intubation and dacryocystorhinostomy. There is considerable variation as to the timing of these interventional techniques.

Mesh:

Year:  2001        PMID: 11720151     DOI: 10.1046/j.1442-9071.2001.00433.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  5 in total

1.  The course of epiphora after failure of silicone intubation for congenital nasolacrimal duct obstruction.

Authors:  Yanir Kassif; Uri Rehany; Michal David; Anna Popko; Shimon Rumelt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-09       Impact factor: 3.117

2.  Efficacy of probing for children with congenital nasolacrimal duct obstruction: a retrospective study using fluorescein dye disappearance test and lacrimal sac echography.

Authors:  Piero Steindler; Enrico Mantovani; Carlo Incorvaia; Francesco Parmeggiani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-24       Impact factor: 3.117

3.  Balloon catheter dilation and nasolacrimal duct intubation for treatment of nasolacrimal duct obstruction after failed probing.

Authors:  Michael X Repka; Danielle L Chandler; Jonathan M Holmes; Darren L Hoover; Christine L Morse; Susan Schloff; David I Silbert; D Robbins Tien
Journal:  Arch Ophthalmol       Date:  2009-05

4.  Repeat probing for treatment of persistent nasolacrimal duct obstruction.

Authors:  Michael X Repka; Danielle L Chandler; Don L Bremer; Mary Louise Z Collins; Dave H Lee
Journal:  J AAPOS       Date:  2009-06       Impact factor: 1.220

5.  Endonasal dacryocystorhinostomy in children.

Authors:  Denis Knijnik
Journal:  Braz J Otorhinolaryngol       Date:  2005 Nov-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.